GB0211396D0 - New use of ramatroban - Google Patents

New use of ramatroban

Info

Publication number
GB0211396D0
GB0211396D0 GBGB0211396.7A GB0211396A GB0211396D0 GB 0211396 D0 GB0211396 D0 GB 0211396D0 GB 0211396 A GB0211396 A GB 0211396A GB 0211396 D0 GB0211396 D0 GB 0211396D0
Authority
GB
United Kingdom
Prior art keywords
ramatroban
new use
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB0211396.7A
Other versions
GB2388540A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Priority to GB0211396A priority Critical patent/GB2388540A/en
Publication of GB0211396D0 publication Critical patent/GB0211396D0/en
Publication of GB2388540A publication Critical patent/GB2388540A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
GB0211396A 2002-05-17 2002-05-17 New use of Ramatroban Withdrawn GB2388540A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB0211396A GB2388540A (en) 2002-05-17 2002-05-17 New use of Ramatroban

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0211396A GB2388540A (en) 2002-05-17 2002-05-17 New use of Ramatroban

Publications (2)

Publication Number Publication Date
GB0211396D0 true GB0211396D0 (en) 2002-06-26
GB2388540A GB2388540A (en) 2003-11-19

Family

ID=9936917

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0211396A Withdrawn GB2388540A (en) 2002-05-17 2002-05-17 New use of Ramatroban

Country Status (1)

Country Link
GB (1) GB2388540A (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100406007C (en) 2002-12-20 2008-07-30 安姆根有限公司 Asthma and allergic inflammation modulators
DE602005006539D1 (en) 2004-03-11 2008-06-19 Actelion Pharmaceuticals Ltd TETRAHYDROPYRIDOINDOLDERIVATE
US8022063B2 (en) 2004-05-29 2011-09-20 7Tm Pharma A/S CRTH2 receptor ligands for medicinal uses
EP1758571A1 (en) * 2004-05-29 2007-03-07 7TM Pharma A/S Crth2 receptor ligands for therapeutic use
AU2005276640A1 (en) 2004-08-26 2006-03-02 Actelion Pharmaceuticals Ltd. 2-sulfanyl-benzoimidazol-1-yl-acetic acid derivatives as CRTH2 antagonists
MX2007007691A (en) * 2004-12-27 2007-08-14 Actelion Pharmaceuticals Ltd 2,3,4,9-tetrahydro-1h-carbazole derivatives as crth2 receptor antagonists.
WO2006125784A1 (en) * 2005-05-24 2006-11-30 Laboratoires Serono S.A. Tricyclic spiro derivatives as crth2 modulators
GB0524428D0 (en) 2005-11-30 2006-01-11 7Tm Pharma As Medicinal use of receptor ligands
PT2051962E (en) 2006-08-07 2012-01-10 Actelion Pharmaceuticals Ltd (3-amino-1,2,3,4-tetrahydro-9h-carbazol-9-yl)-acetic acid derivatives
ES2471919T3 (en) 2007-12-19 2014-06-27 Amgen, Inc Phenylacetic acid derivatives as inflammation modulators
AU2011231208B2 (en) 2010-03-22 2015-03-26 Idorsia Pharmaceuticals Ltd 3-(heteroaryl-amino)-1,2,3,4-tetrahydro-9H-carbazole derivatives and their use as prostaglandin D2 receptor modulators
KR101920090B1 (en) 2010-07-05 2018-11-19 이도르시아 파마슈티컬스 리미티드 1-phenyl-substituted heterocyclyl derivatives and their use as prostaglandin d2 receptor modulators
EP2457900A1 (en) 2010-11-25 2012-05-30 Almirall, S.A. New pyrazole derivatives having CRTh2 antagonistic behaviour
SG193902A1 (en) 2011-04-14 2013-11-29 Actelion Pharmaceuticals Ltd 7-(heteroaryl-amino)-6,7,8,9-tetrahydropyrido[1,2-a]indol acetic acid derivatives and their use as prostaglandin d2 receptor modulators
CA2858328A1 (en) 2011-12-21 2013-06-27 Actelion Pharmaceuticals Ltd Heterocyclyl derivatives and their use as prostaglandin d2 receptor modulators
WO2014006585A1 (en) 2012-07-05 2014-01-09 Actelion Pharmaceuticals Ltd 1-phenyl-substituted heterocyclyl derivatives and their use as prostaglandin d2 receptor modulators
BR112016021471B1 (en) 2014-03-17 2022-10-11 Idorsia Pharmaceuticals Ltd COMPOUNDS DERIVED FROM ACETIC ACID AZAINDOL, PHARMACEUTICAL COMPOSITION, AND, USE OF A COMPOUND
US9850241B2 (en) 2014-03-18 2017-12-26 Idorsia Pharmaceuticals Ltd Azaindole acetic acid derivatives and their use as prostaglandin D2 receptor modulators
KR20180053345A (en) 2015-09-15 2018-05-21 이도르시아 파마슈티컬스 리미티드 Crystalline form
JP7122499B2 (en) * 2016-06-03 2022-08-22 幸久 村田 cancer metastasis inhibitor

Also Published As

Publication number Publication date
GB2388540A (en) 2003-11-19

Similar Documents

Publication Publication Date Title
PL372902A1 (en) New use
IL173440A0 (en) Novel formulation of ropinirole
GB0206048D0 (en) Use
GB0227666D0 (en) Use
GB0211396D0 (en) New use of ramatroban
ZA200407609B (en) Use of vitamin d compounds
GB0217056D0 (en) Use
GB0213878D0 (en) Use
GB0206838D0 (en) Use
AU2002952559A0 (en) New use
GB0313913D0 (en) New use
PL377902A1 (en) Novel use of phosphor-nitrogen-metal complex
GB0204720D0 (en) Novel use
GB0230343D0 (en) Use
AU2003238034A1 (en) Novel use of imidazotriazinones
GB0210682D0 (en) Novel use
HUP0203929D0 (en) New use of substituted alkyl-piridazinone derivatives
GB0217750D0 (en) New use of diaza-anthracene compounds
GB0218043D0 (en) New use of diaza-anthracene compounds
GB0327619D0 (en) New use
PL356853A1 (en) Application of bacteriphages
GB0229442D0 (en) Use
SI1537210T1 (en) Decoy-oligonucleotide-inhbition of cd40-expression
GB0200737D0 (en) New use
GB0218422D0 (en) New use

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)